These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 33519771)

  • 1. Targeting Autophagy as a Strategy for Developing New Vaccines and Host-Directed Therapeutics Against Mycobacteria.
    Strong EJ; Lee S
    Front Microbiol; 2020; 11():614313. PubMed ID: 33519771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy-activating strategies to promote innate defense against mycobacteria.
    Kim YS; Silwal P; Kim SY; Yoshimori T; Jo EK
    Exp Mol Med; 2019 Dec; 51(12):1-10. PubMed ID: 31827065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA-Approved Amoxapine Effectively Promotes Macrophage Control of Mycobacteria by Inducing Autophagy.
    Wang J; Sha J; Strong E; Chopra AK; Lee S
    Microbiol Spectr; 2022 Oct; 10(5):e0250922. PubMed ID: 36129262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy and Host Defense in Nontuberculous Mycobacterial Infection.
    Silwal P; Kim IS; Jo EK
    Front Immunol; 2021; 12():728742. PubMed ID: 34552591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host-directed therapy to combat mycobacterial infections.
    Kilinç G; Saris A; Ottenhoff THM; Haks MC
    Immunol Rev; 2021 May; 301(1):62-83. PubMed ID: 33565103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunology of other mycobacteria: M. ulcerans, M. leprae.
    Röltgen K; Pluschke G; Spencer JS; Brennan PJ; Avanzi C
    Semin Immunopathol; 2020 Jun; 42(3):333-353. PubMed ID: 32100087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy Induction as a Host-Directed Therapeutic Strategy against
    Adikesavalu H; Gopalaswamy R; Kumar A; Ranganathan UD; Shanmugam S
    Medicina (Kaunas); 2021 May; 57(6):. PubMed ID: 34070995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterium tuberculosis PE_PGRS20 and PE_PGRS47 Proteins Inhibit Autophagy by Interaction with Rab1A.
    Strong EJ; Ng TW; Porcelli SA; Lee S
    mSphere; 2021 Aug; 6(4):e0054921. PubMed ID: 34346699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-23a-5p modulates mycobacterial survival and autophagy during mycobacterium tuberculosis infection through TLR2/MyD88/NF-κB pathway by targeting TLR2.
    Gu X; Gao Y; Mu DG; Fu EQ
    Exp Cell Res; 2017 May; 354(2):71-77. PubMed ID: 28327409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Targeting of Mycobacteria through Cell Surface Glycan Engineering.
    Dzigba P; Rylski AK; Angera IJ; Banahene N; Kavunja HW; Greenlee-Wacker MC; Swarts BM
    ACS Chem Biol; 2023 Jul; 18(7):1548-1556. PubMed ID: 37306676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy: A new strategy for host-directed therapy of tuberculosis.
    Paik S; Kim JK; Chung C; Jo EK
    Virulence; 2019 Dec; 10(1):448-459. PubMed ID: 30322337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Zhu R; Shang Y; Chen S; Xiao H; Ren R; Wang F; Xue Y; Li L; Li Y; Chu N; Huang H
    Microbiol Spectr; 2022 Dec; 10(6):e0137222. PubMed ID: 36250885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Two-Step Real-Time PCR Method To Identify Mycobacterium tuberculosis Infections and Six Dominant Nontuberculous Mycobacterial Infections from Clinical Specimens.
    Park J; Kwak N; Chae JC; Yoon EJ; Jeong SH
    Microbiol Spectr; 2023 Aug; 11(4):e0160623. PubMed ID: 37378523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of autophagy as a strategy for development of new vaccine candidates against tuberculosis.
    Flores-Valdez MA; Segura-Cerda CA; Gaona-Bernal J
    Mol Immunol; 2018 May; 97():16-19. PubMed ID: 29547747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dimethyl itaconate is effective in host-directed antimicrobial responses against mycobacterial infections through multifaceted innate immune pathways.
    Kim YJ; Park EJ; Lee SH; Silwal P; Kim JK; Yang JS; Whang J; Jang J; Kim JM; Jo EK
    Cell Biosci; 2023 Mar; 13(1):49. PubMed ID: 36882813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A CD4+CD161+ T-Cell Subset Present in Unexposed Humans, Not Tb Patients, Are Fast Acting Cells That Inhibit the Growth of Intracellular Mycobacteria Involving CD161 Pathway, Perforin, and IFN-γ/Autophagy.
    Yang R; Peng Y; Pi J; Liu Y; Yang E; Shen X; Yao L; Shen L; Modlin RL; Shen H; Sha W; Chen ZW
    Front Immunol; 2021; 12():599641. PubMed ID: 33732233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterium tuberculosis PPE51 Inhibits Autophagy by Suppressing Toll-Like Receptor 2-Dependent Signaling.
    Strong EJ; Wang J; Ng TW; Porcelli SA; Lee S
    mBio; 2022 Jun; 13(3):e0297421. PubMed ID: 35467412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cutaneous and soft skin infections due to non-tuberculous mycobacteria].
    Alcaide F; Esteban J
    Enferm Infecc Microbiol Clin; 2010 Jan; 28 Suppl 1():46-50. PubMed ID: 20172423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.